↓ Skip to main content

Naftidrofuryl for dementia

Overview of attention for article published in Cochrane database of systematic reviews, December 2011
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Naftidrofuryl for dementia
Published in
Cochrane database of systematic reviews, December 2011
DOI 10.1002/14651858.cd002955.pub4
Pubmed ID
Authors

DongHao Lu, Huan Song, Zilong Hao, Taixiang Wu, Jenny McCleery

Abstract

Dementia is a brain disorder characterized by the permanent loss of higher cognitive functions. A number of vasodilatory drug treatments are prescribed for dementia. Naftidrofuryl is one such medicine which is reported to improve clinical symptoms significantly. The efficacy and possible adverse events of naftidrofuryl need to be reviewed systematically and assessed critically to inform clinical practice and guide the continued search for new treatment regimens.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 6%
Unknown 16 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 76%
Student > Bachelor 9 53%
Student > Doctoral Student 7 41%
Student > Ph. D. Student 6 35%
Student > Postgraduate 5 29%
Other 13 76%
Readers by discipline Count As %
Medicine and Dentistry 21 124%
Nursing and Health Professions 6 35%
Psychology 5 29%
Neuroscience 4 24%
Social Sciences 3 18%
Other 9 53%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 May 2012.
All research outputs
#10,023,986
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#8,365
of 8,923 outputs
Outputs of similar age
#84,046
of 118,777 outputs
Outputs of similar age from Cochrane database of systematic reviews
#91
of 105 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 118,777 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 105 others from the same source and published within six weeks on either side of this one. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.